Diakine-DK4 10 (CD14)

N/A

Report date: 2023/03/07 16:09:40

Base Information

Drug NameDiakine-DK4 10 (CD14)
Drug Alias NameDiakine™- DK4 10 (CD14)Diakine™- DK410 (CD14)
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionInterleukin-4 receptors stimulantsInterleukin 10 receptor stimulantsAnti-CD14
TargetsInterleukin-4 receptorsInterleukin 10 receptorMonocyte differentiation antigen CD14
Therapy Area/IndicationsSepsis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDeka Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesDeka Biosciences Inc
Inactive CompaniesN/A
Active IndicationsSepsis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A